Girl Girl Young Girl RSS 12

Girl Seductive

2006Äê¹Ø¼ü´Ê×Ü»ã Girl Girl Young Girl RSS 12

Girl Girl Young Girl RSS 12

136 chest CTÐØ²¿¼ÆËã»úÌå²ãÉãÓ°Êõ

137 chest roentgenogramÐØ²¿XÏßÉãÓ°Êõ

138 chet ultrasoundÐØ²¿³¬Éù

139 Cheyne-Strokes respiration³Â£­Ê©Ê½ºôÎü

140 children¶ùͯ

141 Chinese adults³ÉÄ껪ÈË

142 chronic bronchitisÂýÐÔÖ§Æø¹ÜÑ×

143 chronic cough Young ÐÈËÔ

144 chroni d liver diseaseÂýÐԸβ¡

145 chronicobstructiveÂýÐÔ×èÈûÐÔ

146 ciclesonide»·Ë÷ÄεÂ

147 ciliaÏËë

148 cilomilastÎ÷ÂåË¾ÌØ

149 classification·ÖÀàh

150 clinical characteristicsÁÙ´²ÌØÕ÷

151 clinical gestaltÁÙ´²ÕûºÏÅжÏ

152 clinical outcomeÁÙ´²½á¹û

153 clinical prediction ruleÁÙ´²Ô¤²â¹æÔò

154 coagulation systemÄýѪϵͳ

155 codes of ethicsµÀµÂ±ê×¼

156 cognitive aspectsÈÏÖª¶È

157 cognitive impairmentÈÏÖªËðº¦

158 cohort studies¶ÓÁÐÑо¿

159 colony-stimulating factors ¼¯Âä´Ì¼¤Òò×Ó

160 coma»èÃÔ

161 comet-tailåçÐÇβ

162 community-acquired pneumoniaÉçÇø»ñµÃÐÔ·ÎÑ×

163 comorbiditiesºÏ²¢Ö¢

164 complianceÒÀ´ÓÐÔ

165 complications²¢·¢Ö¢

166 complications of surgeryÊÖÊõ²¢·¢Ö¢

167 computer programs¼ÆËã»ú³ÌÐò

168 concentration of NOÒ»Ñõ»¯Ì¼Å¨¶È

169 congenital heart diseaseÏÈÌìÐÔÐÄÔಡ

170 congestive heart failure³äѪÐÔÐÄÁ¦Ë¥½ß

171 connective tissue disease½áµÞ×éÖ¯¼²²¡

172 consensus statement¹²Ê¶ÉùÃ÷

173 conservative treatment±£ÊØÖÎÁÆ

174 continuous positive airway pressure³ÖÐøÆøµÀÕý

ѹ

175 control¿ØÖÆ

176 control of breathingºôÎü¿ØÖÆ

177 COPDÂýÐÔ×èÈûÐԷμ²²¡

178 cor pulmonale·ÎÔ´ÐÔÐÄÔಡ

179 coronary angioplasty¹Ú×´¶¯Âö³ÉÐÎÊõ

180 coronary artery bypass grafting¹Ú×´¶¯ÂöÅÔÂ·ÒÆ

Ö²Êõ

181 coronary artery disease¹Ú×´¶¯Âö¼²²¡

182 coronary artery stenosis¹Ú×´¶¯ÂöÏÁÕ­

183 coronary artery surgery¹Ú×´¶¯ÂöÊÖÊõ

184 corticosteroidƤÖÊÀà¹Ì´¼

185 cost-effectiveness³É±¾£­Ð§¹û

186 costs³É±¾

187 cough sensitivity¿ÈËÔÃô¸ÐÐÔ

188 C-reactive proteinC-·´Ó¦µ°°×

189 creatine phosphokinase¼¡ËáÁ×Ëἤø

190 critical careÖØÖ¢¼à»¤

191 critical powerÁÙ½çÄÜÁ¦

192 critically illÎ£ÖØ²¡

193 CT¼ÆËã»úÌå²ãÉãÓ°Êõ

194 CT-guided intervention¼ÆËã»úÌå²ãÉãÓ°ÊõÒýµ¼½é

195 cyclic guanosine monophosphate»·ÄñÜÕËá

196 cyclophosphamide»·Á×õ£°·

197 cystic fibrosisÄÒÐÔÏËά»¯

D

198 daily activityÈÕ³£»î¶¯

199 d-dimerd-¶þ¾ÛÌå

200 deathËÀÍö

201 decision making¾ö²ß

202 deep inspiration-induced bronchodilationÉîÎüÆø

ÓÕµ¼Ö§Æø¹ÜÀ©ÕÅ

203 deep vein thrombosisÉî¾²ÂöѪ˨ÐγÉ

204 detection¼ì²â

205 diagnosisÕï¶Ï

206 diagnostic imagingÕï¶ÏÏÔÏñ

207 diagnostic studiesÕï¶ÏÐÔÑо¿

208 diagnostic techniquesÕï¶Ï¼¼Êõ

209 diaphragmëõ¼¡

210 diastolic functionÊæÕŹ¦ÄÜ

211 diazepamµØÎ÷ãú

212 differential diagnosis¼ø±ðÕï¶Ï

213 discrimination±æ±ð

214 disease-free intervalÎÞ²¡¼äЪÆÚ

215 dissection½âÆÊ

216 docetaxel¶àÏ©×Ïɼ´¼

217 Doppler¶àÆÕÀÕ

218 Doppler echocardiography¶àÆÕÀÕ³¬ÉùÐĶ¯Í¼

219 drainageÒýÁ÷

220 drug industryÖÆÒ©ÆóÒµ

221 DuplexË«¹¦ÄÜ

222 dying´¹ËÀ

223 dynamic hyperinflation¶¯Ì¬¹ý¶È³äÆø

224 dynamic ventilatory constraint¶¯Ì¬Í¨ÆøÏÞÖÆ

225 dysphagiaÍÌÑÊÀ§ÄÑ

226 dyspneaºôÎüÀ§ÄÑ

227 dyssomnias˯ÃßÒì³£

E

228 early interventionÔçÆÚ¸ÉÔ¤

229 early peripheral lung cancersÔçÆÚÖÜΧÐͷΰ©

230 echocardiography³¬ÉùÐ͝Ãè¼ÇÊõ

231 education½ÌÓý

232 efficacyÓÐЧÐÔ

233 elderlyÀÏÄêÈË

234 electrical stimulationµç´Ì¼¤

235 electronicµç×ÓµÄ

236 emboli˨×Ó

237 emergency department¼±Õï¿Æ

238 emission-CT·¢ÉäÐͼÆËã»úÌå²ãÉãÓ°Êõ

239 endarterectomy¶¯ÂöÄÚĤÇгýÊõ

240 endobronchial ultrasonographyÖ§Æø¹ÜÄÚ³¬Éù

241 endobronchial valveÖ§Æø¹ÜÄÚ»î°ê

242 end-of-life careÁÙÖչػ³

243 endothelial dysfunctionÄÚÆ¤¹¦ÄÜÕϰ­

244 endothelial functionÄÚÆ¤¹¦ÄÜ

245 endotoxinÄÚ¶¾ËØ

246 endotracheal intubationÆø¹ÜÄÚ²å¹Ü

247 end-tidal³±ÆøÄ©

248 enzyme-linked immunosorbent assayøÁªÃâÒßÎü

¸½ÊÔÑé

249 eosinophilicÊÈËáÐÔ

250 eosinophilsÊÈËáϸ°û

251 eotaxin-3ÊÈËáÐÔÁ£Ï¸°ûÇ÷»¯Òò×Ó-3

252 epidemiologyÁ÷Ðв¡Ñ§

253 epidermal growth factor±íƤÉú³¤Òò×Ó

254 epidermal growth factor receptor±íƤÉú³¤Òò×ÓÊÜ

Ìå

255 epithelial cellsÉÏÆ¤Ï¸°û

256 2-[18F]fluoro-2-deoxy-D-glucose positron emission to-

mography2-[18F]·ú-2-ÍÑÑõ-D-ÆÏÌÑÌÇ (FDG)

Õýµç×Ó·¢ÉäÌå²ãÉãÓ°Êõ

257 erythropoietin´Ùºìϸ°ûÉú³ÉËØ

258 ethaneÒÒÍé

259 ethane in exhaled breathºô³öÆøÒÒÍé

260 ethnicityÈËÖÖѧ

261 etiology²¡Òòѧ

262 exacerbations¼±ÐÔ¼ÓÖØ

263 exerciseÔ˶¯

264 exercise capacityÔ˶¯ÄÜÁ¦

265 exercise testingÔ˶¯ÊÔÑé

266 exercise therapyÔ˶¯ÖÎÁÆ

267 exercise toleranceÔ˶¯ÄÍÁ¿

268 exercise trainingÔ˶¯ÑµÁ·

269 exercise-inducedÔ˶¯ÓÕ·¢

270 exercise-induced asthmaÔ˶¯ÓÕ·¢Ïø´­

271 exhaled breath condensateºô³öÆøÀäÄýÒº

272 extrapulmonary tuberculosis·ÎÍâ½áºË

273 extravascular lung waterѪ¹ÜÍâ·ÎË®

274 extravascular lung water indexѪ¹ÜÍâ·ÎˮָÊý

275 extubation failure°Î¹Üʧ°Ü

276 exudatesÉø³öÒº

F

277 fat embolismÖ¬·¾Ë¨Èû

278 fellowship trainingÃâ·ÑÅàѵ

279 femaleÅ®ÐÔ

280 FEV1µÚ1ÃëÓÃÁ¦ºôÆøÁ¿

281 flow-mediated vasodilationѪÁ÷½éµ¼ÐÔѪ¹ÜÀ©ÕÅ

282 flowmetersÁ÷Á¿¼Æ

283 fluorodeoxyglucose·úÍÑÑõÆÏÌÑÌÇ

284 fluoroquinolones·úà­ÅµÍªÀà

285 fluorothymidine·úÐØÜÕ

286 follow-upËæ·Ã

287 follow-up studiesËæ·ÃÑо¿

288 forced expiratory volume in 3 sµÚ3ÃëÓÃÁ¦ºôÆøÁ¿

289 forced oscillation techniqueÓÃÁ¦Õñµ´¼¼Êõ

290 formoterol¸£ÄªÌØÂÞ

291 fractional flow reserveѪÁ÷´¢±¸·ÖÊý

292 FVCÓÃÁ¦·Î»îÁ¿

G

293 gastroesophageal refluxθʳ¹Ü·´Á÷

294 gemcitabine¼ªÎ÷Ëû±õ

295 gender differencesÐÔ±ð²îÒì

296 gene-environmental interactionÒÅ´«£­»·¾³µÄÏ໥

×÷ÓÃ

297 general practiceÈ«¿ÆÒ½Ñ§

298 genetic predispositionÒÅ´«ËØÖÊ

299 genetic predisposition to disease¼²²¡Ò׸ÐÐÔ»ùÒò

300 geographyµØÀí

301 geriatric assessmentÀÏÄêÈËÉíÐĽ¡¿µÆÀ¼Û

302 Ghrelin¼¢¶ñ¼¤ËØ

303 glottic-stop reflexÉùÃűպϷ´Éä

304 glucocorticoidÌÇÆ¤Öʼ¤ËØÀà

305 glucocorticosteroid treatmentÌÇÆ¤ÖÊÀà¹Ì´¼¼¤ËØ

ÖÎÁÆ

306 glucoseÆÏÌÑÌÇ

307 glutathione S-transferase M1¹Èë׸ÊëÄS×ªÒÆÃ¸

M1

308 glutathione S-transferase P1 gene¹Èë׸ÊëÄS×ªÒÆ

øP1»ùÒò

309 goal-directed volume therapyÄ¿±êµ¼ÏòÐÔÈÝÁ¿ÖÎÁÆ

310 goodness-of-fit testÄâºÏÓŶȼìÑé

311 granulocyte macrophage colony-stimulating factor

Á£Ï¸°û¾ÞÊÉϸ°û¼¯Âä´Ì¼¤Òò×Ó

312 granulomaÈâÑ¿Ö×

313 gravityÖØÁ¦

314 guidelinesÖ¸ÄÏ

H

315 Haemophilus influenzaeÁ÷¸ÐÊÈѪ¸Ë¾ú

316 hand-carried ultrasoundÊÖЯʽ³¬Éù

317 haplotypeµ¥±¶ÐÍ

318 hay fever»¨·ÛÈÈ

319 hazard ratio·çÏÕ±È

320 health½¡¿µ

321 health careÎÀÉú±£½¡

322 health services researchÎÀÉú·þÎñÑо¿

323 health status indicators½¡¿µ×´¿öÖ¸±ê

324 health technology assessmentÎÀÉú¼¼ÊõÆÀ¹À

325 health-related quality of life½¡¿µÏà¹ØÉú»îÖÊÁ¿

326 heart diseaseÐÄÔಡ

327 heart failureÐÄÁ¦Ë¥½ß

328 heart rateÐÄÂÊ

329 heartburnÎ¸×ÆÈÈ

330 heliumº¤Æø

331 helmetÍ·¿ø

332 hematocritѪϸ°û±ÈÈÝ

333 hematopoietic stem-cell transplantÔìѪ¸Éϸ°ûÒÆÖ²

334 heme oxygenaseѪºìËØ¼ÓÑõø

335 hemoptysis¿©Ñª

336 hemorrhage³öѪ

337 hemostatic therapyֹѪÖÎÁÆ

338 high dose´ó¼ÁÁ¿

339 high-altitude pulmonary edema¸ßÔ­ÐÔ·ÎË®Ö×

340 high-resolution¸ß·Ö±æ

341 histology×é֯ѧ

342 histopathologic classification×éÖ¯²¡Àíѧ·ÖÀà

343 home exposure¼ÒÍ¥±©Â¶

344 home mechanical ventilation¼ÒÍ¥»úÐµÍ¨Æø

345 homelessÁ÷ÀË

346 homocysteineͬÐͰëë×°±Ëá

347 hospital mortalityסԺ²¡ËÀÂÊ

348 hospital volumeÒ½Ôº¹æÄ£

349 human herpesvirus-8ÈËÀàðåÕ¶¾-8

350 human studyÈËÀàÑо¿

351 hypercapnia¸ß̼ËáѪ֢

352 hypercapnic encephalopathy¸ß̼ËáÄÔ²¡

353 hypercholesterolemia¸ßµ¨¹Ì´¼ÑªÖ¢

354 hyperCKemia¸ß¼¡ËáÁ×ËἤøѪ֢

355 hyperinflation¹ý¶È³äÆø

356 hyperosmolality¸ßÉøÐÔ

357 hypersecretion¸ß·ÖÃÚ

358 hypersensitivity³¬Ãô·´Ó¦

359 hypertension¸ßѪѹ

360 hyperthermia·¢ÈÈ

361 hypothalamo-hypophyseal systemÏÂÇðÄÔ£­´¹Ìå

ϵͳ

362 hypothermiaµÍÎÂ

363 hypovolemiaµÍѪÈÝÁ¿

364 hypoxemiaµÍÑõѪ֢

I

365 ICUÖØÖ¢¼à»¤²¡·¿

366 ICU risk stratification scoreICUΣÏÕ·Ö²ãÆÀ·Ö

367 idiopathic pulmonary arterial hypertensionÔ­·¢

ÐԷζ¯Âö¸ßѹ

368 immediate hypersensitivity³¬Ãô·´Ó¦£¬ËÙ·¢ÐÍ

369 immune modulationÃâÒßµ÷½Ú

370 immune responsivenessÃâÒß·´Ó¦

371 immunosuppressionÃâÒßÒÖÖÆ

372 incidence·¢²¡ÂÊ

373 induced sputumÓÕµ¼Ìµ

374 inducible nitric oxide synthaseÓÕµ¼ÐÍÒ»Ñõ»¯µªºÏ

ø

375 inductive plethysmographyµç¸ÐÓ¦Ìå»ýÃè¼ÇÊõ

376 infantÓ¤¶ù

377 infection¸ÐȾ

378 infection-free intervalÎÞ¸ÐȾ¼äЪÆÚ

379 infectivity´«È¾ÐÔ

380 inflammationÑ×Ö¢

381 information systemsÐÅϢϵͳ

382 inhalationÎüÈë

383 inhalation injuryÎüÈëÐÔËðÉË

384 inhaled corticosteroidsÎüÈëÆ¤ÖÊÀà¹Ì´¼¼¤ËØ

385 insomniaʧÃß

386 inspiratory capacityÉîÎüÆøÁ¿

387 inspiratory muscle trainingÎüÆø¼¡ÑµÁ·

388 integrinsÕûºÏËØ

389 interdisciplinary intervention¶àѧ¿Æ¸ÉÔ¤

390 interference¸ÉÈÅ

391 interferon¸ÉÈÅËØ

392 interferon-g¸ÉÈÅËØ-g

393 interleukin-10°×ϸ°û½éËØ-10

394 interleukin-5°×ϸ°û½éËØ-5

395 interleukin-8°×ϸ°û½éËØ-8

396 internal thoracic arteryÈéÄÚ¶¯Âö

397 interstitial lung disease¼äÖÊÐԷβ¡

398 intervention¸ÉÔ¤

399 interventional procedures½éÈëÖÎÁÆ

400 interventional pulmonology½éÈë·ÎÔಡѧ

401 intrathoracic blood volumeÐØÄÚѪÈÝÁ¿

402 intrathoracic blood volume indexÐØÄÚѪÈÝÁ¿Ö¸Êý

403 intrathoracic lymphadenopathyÐØÇ»ÄÚÁܰͽᲡ±ä

404 intravascular tumorѪ¹ÜÄÚÖ×Áö

405 invasive mechanical ventilationÓд´»úÐµÍ¨Æø

406 invasive pulmonary aspergillosisÇÖÏ®ÐÔ·ÎÇúù¾ú²¡

407 investigationµ÷²é

408 ipratropium bromide nasal sprayÒì±ûÍÐäåï§Åç±Ç

409 ironÌú

410 ischemiaȱѪ

411 ischemia-reperfusion injuryȱѪ£­ÔÙ¹à×¢ËðÉË

412 ischemic strokeȱѪÐÔ×äÖÐ

413 isolated perfused heart·ÖÀëµÄÔÙ¹à×¢ÐÄÔà

K

414 Kaposi sarcoma-associated herpesvirus¿¨²¨Î÷Èâ

ÁöÏà¹ØðåÕ¶¾

415 KITÊÔ¼ÁºÐ

416 Koreaº«¹ú

L

417 laboratoryʵÑéÊÒ

418 lactic acidosisÈéËáËáÖж¾

419 latex-enhanced immunoassayÈ齺ÔöÇ¿ÃâÒ߲ⶨ

420 left atrial appendage×óÐĶú

421 left ventricle×óÐÄÊÒ

422 Legionella¾üÍžú

423 Legionnaires disease¾üÍžú²¡

424 length of stayסԺʱ¼ä

425 less invasive surgery΢´´ÐÔÊÖÊõ

426 leukocyte elastase°×ϸ°ûµ¯ÐÔµ°°×ø

427 leukotriene receptor antagonist°×ÈýÏ©ÊÜÌåÞ׿¹¼Á

428 levalbuterol×óÐýɳ¶¡°·´¼

429 levofloxacin×óÑõ·úɳÐÇ

430 lidocaineÀû¶à¿¨Òò

431 lifestyleÉú»î·½Ê½

432 limited resection¾Ö²¿Çгý

433 lipopolysaccharideÖ¬¶àÌÇ

434 6-min walking test6·ÖÖÓ²½ÐÐÊÔÑé

435 liver¸ÎÔà

436 lobectomyÒ¶Çгý

437 long-acting anticholinergic³¤Ð§¿¹µ¨¼îÄÜÒ©

438 long-acting ¦Â2-agonist³¤Ð§b2-ÊÜÌ弤¶¯¼Á

439 longitudinal study×ÝÏòÑо¿

440 long-term clinical remission³¤ÆÚÁÙ´²»º½â

441 long-term oxygen therapy³¤ÆÚÑõÁÆ

442 lorazepamÀÍÀ­Î÷ãú

443 low-molecular-weight heparinµÍ·Ö×Ó¸ÎËØ

444 lung abscess·ÎŧÖ×

445 lung attenuation·ÎË¥¼õ

446 lung cancer·Î°©

447 lung cancer diagnosis and staging·Î°©Õï¶ÏºÍ·ÖÆÚ

448 lung cancer surgery·Î°©ÊÖÊõ

449 lung diffusion·ÎÃÖÉ¢

450 lung diseases·Î²¿¼²²¡

451 lung elastic recoil·Îµ¯ÐÔ»ØËõÁ¦

452 lung function·Î¹¦ÄÜ

453 lung metastasis·Î×ªÒÆ

r2006Äê¹Ø¼ü´Ê×Ü»ã Girl Girl Young Girl RSS 12y g Seductive Young Seductive q2006Äê¹Ø¼ü´Ê×Ü»ã Girl Girl Young Girl RSS 12c i i Seductive Girl